Literature DB >> 681879

The human complement system in thrombin-mediated platelet function.

M J Polley, R Nachman.   

Abstract

Thrombin-mediated platelet membrane-specific uptake of C3 and C5 was demonstrated by radiolabeled components and was visualized electron microscopically utilizing a ferritin marker conjugated to monospecific antibody to each component. The role of complement in thrombin-induced platelet function was determined. Though complement was not essential for thrombin-induced platelet aggregation and release of serotonin, these activities were significantly increased if complement was present. The release of serotonin was found to be a nonlytic process because under the conditions employed, no lactic dehydrogenase was released. The activation of complement was induced by a mechanism which has not been previously described. Thrombin associated with the platelet membrane presumably formed a C3 convertase that entered the known complement sequence at the C3 stage and proceeded to activate the terminal components through the known sequence to C9.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 681879      PMCID: PMC2184322          DOI: 10.1084/jem.147.6.1713

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Conjugation of antibody to ferritin by means of p,p'-difluoro-m, m'-dinitrodiphenylsulphone.

Authors:  S S TAWDE; J S RAM
Journal:  Arch Biochem Biophys       Date:  1962-05       Impact factor: 4.013

2.  A new supporting medium for preparative electrophoresis.

Authors:  H J MULLER-EBERHARD
Journal:  Scand J Clin Lab Invest       Date:  1960       Impact factor: 1.713

3.  Lactic dehydrogenase activity in blood.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

4.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  A simple method for producing antibody specific to a single selected diffusible antigen.

Authors:  R B Goudie; C H Horne; P C Wilkinson
Journal:  Lancet       Date:  1966-12-03       Impact factor: 79.321

6.  The ninth component of human complement: isolation, description and mode of action.

Authors:  U Hadding; H J Müller-Eberhard
Journal:  Immunology       Date:  1969-06       Impact factor: 7.397

7.  The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets.

Authors:  G N Brodie; N L Baenziger; L R Chase; P W Majerus
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

8.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

9.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

10.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

View more
  32 in total

1.  Plasminogen is a complement inhibitor.

Authors:  Diana Barthel; Susann Schindler; Peter F Zipfel
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18.

Authors:  Osama A Hamad; Ioannis Mitroulis; Karin Fromell; Huda Kozarcanin; Triantafyllos Chavakis; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Thromb Haemost       Date:  2015-08-13       Impact factor: 5.249

Review 3.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

Review 4.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

5.  Inflammatory mediators released by complement-derived peptides.

Authors:  H Bult; A G Herman
Journal:  Agents Actions       Date:  1983-08

Review 6.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Authors:  Carla Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2010-04-28       Impact factor: 3.714

7.  Abnormal platelet function in C3-deficient mice.

Authors:  F C Gushiken; H Han; J Li; R E Rumbaut; V Afshar-Kharghan
Journal:  J Thromb Haemost       Date:  2009-03-05       Impact factor: 5.824

8.  Targeting complement component 5a promotes vascular integrity and limits airway remodeling.

Authors:  Mohammad A Khan; Christian Maasch; Axel Vater; Sven Klussmann; John Morser; Lawrence L Leung; Carl Atkinson; Stephen Tomlinson; Peter S Heeger; Mark R Nicolls
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

9.  Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140).

Authors:  M S Mulligan; M J Polley; R J Bayer; M F Nunn; J C Paulson; P A Ward
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Functional C8 associated with human platelets.

Authors:  F Tedesco; P Densen; M A Villa; G Presani; L Roncelli; V E Rosso di san Secondo
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.